Torthaí cuardaigh - Agathe Waultier‐Rascalou
- 1 - 4 toradh as 4 á dtaispeáint
-
1
Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or Older de réir Lucie Obéric, Frédéric Peyrade, Mathieu Puyade, Christophe Bonnet, Peggy Dartigues-Cuillères, Bettina Fabiani, Philippe Ruminy, Hervé Maisonneuve, Julie Abraham, Catherine Thiéblemont, Pierre Feugier, Gilles Salles, Fontanet Bijou, Gian-Matteo Pica, Gandhi Damaj, Corinne Haïoun, Olivier Casasnovas, H. Farhat, Ronan Le Calloch, Agathe Waultier‐Rascalou, Sandra Malak, Jérôme Paget, Elodie Gat, Hervé Tilly, Fabrice Jardin
Foilsithe / Cruthaithe 2021Artigo -
2
CAR T-cell therapy in primary central nervous system lymphoma: the clinical experience of the French LOC network de réir Marion Alcantara, Caroline Houillier, Marie Blonski, Marie‐Thérèse Rubio, Lise Willems, Agathe Waultier Rascalou, Magali Le Garff‐Tavernier, Karim Maloum, Clotilde Bravetti, Laëtitia Souchet, Damien Roos‐Weil, Véronique Morel, Madalina Uzunov, Carole Metz, Meriem Dhib-Charfi, Stéphanie Nguyen, Natalia Shor, Dimitri Psimaras, Nicolas Weiss, Nathalie Jacque, Silvia Solorzano, Nicolas Gauthier, Marie Le Cann, Françoise Norol, Carole Soussain, Sylvain Choquet
Foilsithe / Cruthaithe 2021Carta -
3
CAR T‐cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real‐life results of the LOC network de réir Sylvain Choquet, Carole Soussain, Nabih Azar, Véronique Morel, Carole Metz, Rénata Ursu, Agathe Waultier‐Rascalou, Roberta Di Blasi, Roch Houot, Laëtitia Souchet, Damien Roos‐Weil, Madalina Uzunov, Stéphanie Nguyen Quoc, Nathalie Jacque, Inès Boussen, Nicolas Gauthier, Maya Ouzegdouh, Marie Blonski, Arnaud Campidelli, Guido Ahle, Blandine Guffroy, Lise Willems, Emilie Corvilain, Maryline Barrié, Marion Alcantara, Magali Le Garff‐Tavernier, Dimitri Psimaras, Nicolas Weiss, Marine Baron, Clotilde Bravetti, Khê Hoang‐Xuan, Frédéric Davi, Natalia Shor, Agustí Alentorn, Caroline Houillier
Foilsithe / Cruthaithe 2024Artigo -
4
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial de réir Xavier Leleu, Cyrille Hulin, Jérôme Lambert, Arthur Bobin, Aurore Perrot, Lionel Karlin, Murielle Roussel, Lydia Montes, Brieuc Chérel, Thomas Chalopin, Borhane Slama, Marie‐Lorraine Chrétien, Kamel Laribi, C. Dingremont, Christophe Roul, Clara Mariette, Sophie Rigaudeau, Claire Calmettes, Mamoun Dib, Mourad Tiab, Laure Vincent, Jacques Delaunay, Alberto Santagostino, Margaret Macro, Emmanuelle Bourgeois, Frédérique Orsini‐Piocelle, Julie Gay, Benoît Bareau, Noémie Bigot, François Vergez, Pierre Lebreton, Reza Tabrizi, Agathe Waultier‐Rascalou, Laurent Frenzel, Ronan Le Calloch, Émilie Chalayer, Thorsten Braun, Florence Lachenal, Sélim Corm, Celine Kennel, Rakiba Belkhir, Jean‐Sébastien Blade, Bertrand Joly, Valentine Richez-Olivier, Hélène Gardeney, Hélène Demarquette, Daniela Robu-Cretu, Laurent Garderet, Muriel Newinger-Porte, Amine Kasmi, Bruno Royer, Pascale Olivier, Bertrand Arnulf, Karim Belhadj, Cyrille Touzeau, Mohamad Mohty, Salomon Manier, Philippe Moreau, Hervé Avet‐Loiseau, Jill Corre, Thierry Façon
Foilsithe / Cruthaithe 2024Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Internal medicine
Medicine
Oncology
Gastroenterology
Lymphoma
Clinical endpoint
Lenalidomide
Multiple myeloma
Primary central nervous system lymphoma
Randomized controlled trial
Surgery
Biology
Bortezomib
CD34
CHOP
Cancer
Central nervous system
Chemotherapy
Chimeric antigen receptor
Confidence interval
Cyclophosphamide
Cytokine release syndrome
Dexamethasone
Diffuse large B-cell lymphoma
Genetics
Immunotherapy
Leukapheresis
Odds ratio
Pediatrics
Prednisone